Prognostic importance of TPS at colorectal carcinoma and breast cancer.

被引：0
作者：
Topolcan, Ondrej
Holubec jr., Lubos
Svobodova, Sarka
Treska, Vladislav
Bartos, Vladimir
Liska, Vaclav
Kormunda, Stanislav
Sutnar, Alan
Rupert, Karel
Safarcik, Kristian
机构：
[1] Charles Univ Prague, Med Fac Pilsen, Prague, Czech Republic
[2] Charles Univ Prague, Med Fac Prague 1, Prague, Czech Republic
[3] Charles Univ Prague, Fac Hosp Ostava, Prague, Czech Republic
来源：
TUMOR BIOLOGY | 2006年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The importance of ongoing nutritional assessment in advanced colorectal cancer.
    Grutsch, J
    Gupta, D
    Lammersfeld, CA
    Vashi, PG
    Lis, CG
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 292S - 292S
  • [22] Predictive and prognostic factors of apatinib in metastatic colorectal cancer.
    Wang, Fen
    Wang, Shubin
    Yuan, Xia
    Jia, Jun
    Bi, Xiaoxia
    Zhou, Zeqiang
    Zhou, Qiming
    Li, Xia
    Luo, Changguo
    Deng, Minghui
    Yi, Liangjie
    Li, Yong
    Lu, Jianxin
    Su, Wenzhi
    Chen, Hanbin
    Zhu, Yu
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [23] RAS heterogeneity as a prognostic marker in metastatic colorectal cancer.
    Loree, Jonathan M.
    Lam, Michael
    Morris, Jeffrey
    Overman, Michael J.
    Raghav, Kanwal Pratap Singh
    Eng, Cathy
    Dasari, A.
    Kee, Bryan K.
    Fogelman, David R.
    Wolff, Robert A.
    Jiang, Zhiqin
    Davis, Jennifer S.
    Shaw, Kenna Rael
    Broaddus, Russell
    Routbort, Mark
    Luthra, Rajyalakshmi
    Maru, Dipen M.
    Menter, David
    Meric-Bernstam, Funda
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [24] COMPREHENSIVE AND SYSTEMATIC PROGNOSTIC ANALYSIS OF DMMR COLORECTAL CANCER.
    Lv, J.
    DISEASES OF THE COLON & RECTUM, 2022, 65 (05) : 47 - 48
  • [25] Relevant prognostic markers involved in apoptosis in colorectal cancer.
    Gasser, M
    Bueter, M
    Grimm, M
    Hom, S
    Koenigshausen, M
    Thalheimer, A
    Mueller, S
    Thiede, A
    Gassel, HJ
    Meyer, D
    Waaga-Gasser, AM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 876S - 876S
  • [26] The prognostic Significance of Thymidine phosphorylase in Breast cancer.
    Ruckhaeberle, E.
    Karn, T.
    Engels, K.
    Hanker, L.
    Gaetje, R.
    Holtrich, U.
    Rody, A.
    Kaufmann, M.
    ONKOLOGIE, 2010, 33 : 16 - 16
  • [27] Survival and prognostic factors in oligometastatic breast cancer.
    Van Ommen-Nijhof, Annemiek
    Steenbruggen, Tessa Gerjanne
    Capel, Laura C.
    Vergouwen, Michel J. P.
    Peeters, Marie-Jeanne T. F. D. Vrancken
    Wiersma, Terry G.
    Sonke, Gabe S.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [28] Osteoprotegerin (OPG) as a prognostic marker in breast cancer.
    Maslyukova, Elizaveta
    Zabroda, Sergey I.
    Koritova, Luiza
    Korytov, Oleg
    Odincov, V.
    Sergeev, Vladimir
    Odincova, Svetlana
    Raskin, Grigoriy
    Vlasova, Ekaterina
    Obuhov, Evgenii
    Bondarenko, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [29] Prognostic impact of multifocal and multicentric breast cancer compared with unifocal breast cancer.
    Fushimi, Atsushi
    Yoshida, Atsushi
    Yagata, Hiroshi
    Takahashi, Osamu
    Hayashi, Naoki
    Suzuki, Koyu
    Tsunoda, Hiroko
    Nakamura, Seigo
    Yamauchi, Hideko
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [30] Tumor recurrence and the prognostic value of pathologic tumor characteristics in breast cancer. An additive predictive effect of histologic prognostic indicators in breast carcinoma
    De Maeyer, A
    Exner, K
    Holtermuller, KH
    Herzog, P
    Lemperle, G
    Colaert, J
    10TH INTERNATIONAL CONGRESS ON SENOLOGY - BREAST DISEASES OF THE SENOLOGIC INTERNATIONAL SOCIETY, 1998, : 621 - 626
12345